TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( (HK:6990) ) just unveiled an update.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced its plan to implement full circulation of its H shares, converting domestic and unlisted foreign shares into H shares, pending regulatory approvals. This move aims to enhance the company’s share capital structure and market presence, with proposed amendments to its Articles of Association reflecting these changes.
The most recent analyst rating on (HK:6990) stock is a Hold with a HK$434.36 price target. To see the full list of analyst forecasts on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H stock, see the HK:6990 Stock Forecast page.
More about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a joint stock company incorporated in China, operating in the biopharmaceutical industry. The company focuses on developing and manufacturing biopharmaceutical products, with a market presence in Hong Kong.
Average Trading Volume: 817,589
Technical Sentiment Signal: Buy
Current Market Cap: HK$119.3B
Learn more about 6990 stock on TipRanks’ Stock Analysis page.